Minireviews
Copyright ©The Author(s) 2025.
World J Crit Care Med. Sep 9, 2025; 14(3): 103458
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.103458
Table 2 Summary of the protective effects of different klotho regulators in different sepsis models
Klotho regulator
Sepsis model
Mechanism
Effect
Ref.
Treated mice with klotho protein (0.02 mg/kg) for 4 daysLPSKlotho administration/attenuates the reactive oxygen species/p38-mitogen activated protein kinase signaling pathwayReversal of myocardial injury. Reduction in atrial and brain natriuretic peptide (atrial natriuretic peptide and BNP). Reduction in apoptosisYan et al[31]
Recombinant klotho proteinCLPRestoration of endogenous klotho expressionAlleviated CLP-induced acute renal injury by reducing serum creatinine and BUN levelsChen et al[13]
Recombinant klotho proteinLPSKlotho administration/suppression of NF-κB activationCardiac function was improved. Lower myocardial levels of chemokines and cytokines TNF-α, IL-6, and IL-1βHui et al[25]
Recombinant klotho proteinLPSAnti-inflammatory effect of klotho administration/suppression of IL-6 and adhesion moleculesReturn to the baseline levels for myocardial ICAM-1, VCAM-1, and IL-6. Recovery from cardiac dysfunctionLi et al[22]
Recombinant IL-37LPSAnti-inflammatory effect of IL-37/klotho upregulation/suppression of IL-6 and adhesion moleculesImprovement of cardiac functionsLi et al[22]
Pretreatment-recombinant α-klotho proteinLPSAntiapoptotic mechanism through caspase-3 reduction. Anti-inflammatory by shifting the balance towards an anti-inflammatory environment. Antioxidant activitiesAmelioration of septic cardiorenal injury. Reduction in serum levels of troponin, NGAL, BNP, and creatinine. Reduction in the renal cytokines IL-6, IL-1, and TNF-α levels, with marked elevation in IL-10. Reduction in malondialdehyde and nitric oxide productionLiu et al[41]
Recombinant human-klotho proteinCLP. LPS in-vitro study in the human HK2 epithelial cell lineKlotho exerts its protective effects by upregulating nuclear factor erythroid related factor 2 to suppress the ferroptosis signaling pathwayAlleviated kidney injury and increased HK2 cell viability. Administration of klotho upregulates klotho expression in blood, renal tissue, and HK2 cells. Low levels of the inflammatory factors TNF-α and IL-6 and oxidative stress responses. Improvement in mitochondrial number, structure, and function in HK2 cellsZhou et al[14]
Recombinant α-klotho proteinIn-vitro LPS administration to HPAEpiCs. CLP in-vivoPrevents activation of the Bcl-2/Bax/caspase-3 signaling pathwayKlotho increased mouse survival and decreased IL-1β, IL-6, and TNF-α levels. Reducing the percentage of apoptotic cells in lung tissue and HPAEpiCs exposed to LPSLi et al[42]
Treatment with human Wharton’s Jelly-Derived Mesenchymal Stem CellsCLPKlotho protein expression was high. Reduction in NF-κB tissue expression. Expression of Bax was reduced, whereas Bcl-X was increasedSurvival was improved. Glomerular filtration rate and renal and liver functions were improved. Reduction in apoptosis. Levels of the proinflammatory cytokines IL-1α, IL-6, interferon-γ, and TNF-α were reduced. Endothelial function was improvedCóndor et al[23]
Resveratrol and
Recombinant murine α-klotho protein
CLPIncreased tissue expression of klotho protein in both treated groups. The expression of Bax and caspase-3 was reduced, whereas that of Bcl-2 was increased. The reno-protective effect exerted by klotho is through the antiapoptotic effectResveratrol has the same effect as exogenous administration of the klotho protein. Improvement in renal function and structure, decrease in serum creatinine and BUNChen et al[35]
Recombinant klotho proteinLPSReduced level of myeloid peroxidase. Attenuation of renal and brain E-selectin, VCAM-1, ICAM-1 mRNA, endothelial adhesion molecule expression, and neutrophil infiltrationRenal and brain inflammation were reduced. Low plasma BUN and plasma NGAL levels. Decreased renal and brain levels of IL-6, IL-1β, IL-8 and TNF-αJou-Valencia et al[38]